ArticleAnnals of surgical oncology2025
Enucleation of Pancreatic Lesions: The Outcomes and Experiences from Two Centers.
Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundPancreatic fistulas are the most common complication of pancreatic enucleation, which presents certain challenges. This study reported the relevant experiences of two centers regarding the reduction of clinical complications after pancreatic enucleation.
methodsClinical, pathologic, and follow-up data of 31 patients who underwent pancreatic enucleation at the Renmin Hospital of Wuhan University and Sinopharm Gezhouba Central Hospital between January 2019 and October 2024 were retrospectively analyzed. The occurrences of postoperative complications were observed and analyzed.
resultsThe nasopancreatic tubes were successfully placed preoperatively in 26 of the 31 patients. Injury to the main pancreatic duct was found in two cases during the operation. In eight cases, leakage with blue staining on the wound surface was detected using methylene blue injection through the nasopancreatic tube. Postoperatively, 16 cases of pancreatic fistulas were identified including 12 biochemical leaks and 4 grade B fistulas, with no grade C fistulas reported. Three patients experienced mild pancreatitis postoperatively and were cured with conservative treatment. Two patients experienced postoperative infections, one of whom also had delayed gastric emptying. No cases of bile fistula, lymphatic fistula, or perioperative death occurred. During the follow-up period, no tumor recurrence, new-onset diabetes, or dyspepsia requiring pancreatic enzyme supplementation was observed.
conclusionEnucleation is a clinically safe and feasible approach for treating benign and low-grade malignant pancreatic lesions. Preoperative placement of a nasopancreatic tube and injection of methylene blue can aid in detecting potential pancreatic leakage during surgery and offer advantages for tumors near the main pancreatic duct.
Indexed as
Identifiers
40684021What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.